LABCORP HOLDINGS INC. 4

Labcorp executive Brian J. Caveney received an award of 3,000 Restricted Stock Units of Labcorp Holdings Inc. common stock.

On September 1, 2026, Brian J. Caveney, EVP, President of BLS, CMO & CSO of Labcorp Holdings Inc., received an award of 3,000 Restricted Stock Units (RSUs), each representing the right to receive one share of Labcorp common stock, with vesting in three equal annual installments beginning September 1, 2027. The RSUs were granted at no cash cost to the insider, implying an approximate grant-date value of about $995,000 based on the current share price of roughly $331.66. Following this award, Caveney beneficially owns 7,170 RSUs, which at the same indicative price are worth approximately $2.38 million, reflecting a routine equity-based compensation grant rather than an open-market purchase or sale.

Filing Facts

CIK

920148

Ticker

LH

Form

4

Source Type

fda

Accession

0000920148-26-000190

Alert Tier

5